Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mike Partridge

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Radiation Oncology (London, England)|June 26, 2014
Challenges in using ¹⁸F-fluorodeoxyglucose-PET-CT to define a biological radiotherapy boost volume in locally advanced pancreatic cancerJames M Wilson, Somnath Mukherjee, Kwun-Ye Chu, et al.
Physics in Medicine and Biology|October 15, 2009
Assessing correlations between the spatial distribution of the dose to the rectal wall and late rectal toxicity after prostate radiotherapy: an analysis of data from the MRC RT01 trial (ISRCTN 47772397)Florian Buettner, Sarah L Gulliford, Steve Webb, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 24, 2012
The dose-response of the anal sphincter region--an analysis of data from the MRC RT01 trialFlorian Buettner, Sarah L Gulliford, Steve Webb, et al.
Physics in Medicine and Biology|July 27, 2004
A geometric model for evaluating the effects of inter-fraction rectal motion during prostate radiotherapyLuciana M Pavel-Mititean, Carl G Rowbottom, Charlotte L Hector, et al.
Journal of the Royal Society, Interface|March 4, 2016
Estimating oxygen distribution from vasculature in three-dimensional tumour tissueDavid Robert Grimes, Pavitra Kannan, Daniel R Warren, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 29, 2011
Parameters for the Lyman Kutcher Burman (LKB) model of Normal Tissue Complication Probability (NTCP) for specific rectal complications observed in clinical practiseSarah L Gulliford, Mike Partridge, Matthew R Sydes, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2016
An Analysis of Plan Robustness for Esophageal Tumors: Comparing Volumetric Modulated Arc Therapy Plans and Spot Scanning Proton PlanningSamantha Warren, Mike Partridge, Alessandra Bolsi, et al.
Plos One|April 19, 2016
The Role of Oxygen in Avascular Tumor GrowthDavid Robert Grimes, Pavitra Kannan, Alan McIntyre, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 11, 2008
Effective avoidance of a functional spect-perfused lung using intensity modulated radiotherapy (IMRT) for non-small cell lung cancer (NSCLC): an update of a planning studyKonstantin Lavrenkov, Shalini Singh, Judith A Christian, et al.
Acta Oncologica (Stockholm, Sweden)|July 29, 2008
Evaluation of the role of 18FDG-PET/CT in radiotherapy target definition in patients with head and neck cancerKatie L Newbold, Mike Partridge, Gary Cook, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Radiation Oncology (London, England)|June 26, 2014
Challenges in using ¹⁸F-fluorodeoxyglucose-PET-CT to define a biological radiotherapy boost volume in locally advanced pancreatic cancerJames M Wilson, Somnath Mukherjee, Kwun-Ye Chu, et al.
Physics in Medicine and Biology|October 15, 2009
Assessing correlations between the spatial distribution of the dose to the rectal wall and late rectal toxicity after prostate radiotherapy: an analysis of data from the MRC RT01 trial (ISRCTN 47772397)Florian Buettner, Sarah L Gulliford, Steve Webb, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 24, 2012
The dose-response of the anal sphincter region--an analysis of data from the MRC RT01 trialFlorian Buettner, Sarah L Gulliford, Steve Webb, et al.
Physics in Medicine and Biology|July 27, 2004
A geometric model for evaluating the effects of inter-fraction rectal motion during prostate radiotherapyLuciana M Pavel-Mititean, Carl G Rowbottom, Charlotte L Hector, et al.
Journal of the Royal Society, Interface|March 4, 2016
Estimating oxygen distribution from vasculature in three-dimensional tumour tissueDavid Robert Grimes, Pavitra Kannan, Daniel R Warren, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 29, 2011
Parameters for the Lyman Kutcher Burman (LKB) model of Normal Tissue Complication Probability (NTCP) for specific rectal complications observed in clinical practiseSarah L Gulliford, Mike Partridge, Matthew R Sydes, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2016
An Analysis of Plan Robustness for Esophageal Tumors: Comparing Volumetric Modulated Arc Therapy Plans and Spot Scanning Proton PlanningSamantha Warren, Mike Partridge, Alessandra Bolsi, et al.
Plos One|April 19, 2016
The Role of Oxygen in Avascular Tumor GrowthDavid Robert Grimes, Pavitra Kannan, Alan McIntyre, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 11, 2008
Effective avoidance of a functional spect-perfused lung using intensity modulated radiotherapy (IMRT) for non-small cell lung cancer (NSCLC): an update of a planning studyKonstantin Lavrenkov, Shalini Singh, Judith A Christian, et al.
Acta Oncologica (Stockholm, Sweden)|July 29, 2008
Evaluation of the role of 18FDG-PET/CT in radiotherapy target definition in patients with head and neck cancerKatie L Newbold, Mike Partridge, Gary Cook, et al.
Pageof 6